This product is an aminoglycoside antibiotic with an antibacterial spectrum similar to that of gentamicin. It has antibacterial effects on a variety of Gram-negative bacteria and Staphylococcus aureus (including beta-lactamase-producing strains); Streptococci, anaerobic bacteria, Mycobacterium tuberculosis, Rickettsia, viruses and fungi are resistant to this product. This product is stable to aminoglycoside acetyltransferase AAC (6) produced by bacteria, with a minimum inhibitory concentration of 0.1 to 6.25 mg/L. The mechanism of action is to bind to the 30S subunit of the bacterial ribosome and inhibit the synthesis of bacterial proteins.

This product is an aminoglycoside antibiotic. The antibacterial spectrum is similar to that of gentamicin. It has antibacterial effects on Gram-negative bacteria such as Escherichia coli, aerogenes, Klebsiella, Proteus mirabilis, some indole-positive Proteus, Pseudomonas aeruginosa, some Neisseria, some non-pigmented Serratia and Shigella. Among Gram-positive bacteria, Staphylococcus aureus (including beta-lactamase-producing strains) is sensitive to this product; Streptococci (including Streptococcus pyogenes, Pneumococcus, Streptococcus faecalis, etc.) are all resistant to this product. Anaerobic bacteria (Bacteroides), Mycobacterium tuberculosis, Rickettsia, viruses and fungi are also resistant to this product. This product is stable to aminoglycoside acetyltransferase AAC (6) produced by bacteria, so it still has antibacterial activity against bacteria that are resistant to kanamycin, gentamicin, amikacin, ribosomycin, etc. due to the production of this enzyme. The minimum inhibitory concentration of this product is 0.1-6.25 mg/L. The mechanism of action of this product is to bind to the bacterial ribosome 30S subunit and inhibit the synthesis of bacterial protein.

Inhibits prostaglandin synthesis and has antipyretic and analgesic effects

Central nervous system stimulant, can enhance the antipyretic and analgesic effects of the above drugs

alpha;-(Hydroxymethyl)phenylacetic acid 8-methyl-8-azabicyclo[3,2,1]-3-octyl ester sulfate monohydrate Molecular weight: C34H46N2O6.H2SO4.H2O

This product belongs to the butyrophenone antipsychotic drug. Its antipsychotic effect is related to its ability to block dopamine receptors in the brain and promote the conversion of dopamine in the brain. It has a good effect on resisting hallucinations and delusions and excitement and agitation, has a strong effect in blocking extrapyramidal dopamine, and also has a strong antiemetic effect, but its sedative effect and blocking effects on adrenaline receptors and cholinergic receptors are weak.